(Q57898631)
Statements
Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril (English)
G Gamble
S MacMahon
N Sharpe
A Clague
T Clark
H Hart
J Scott